ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 159 filers reported holding ALLAKOS INC in Q4 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,303,000 | +95.5% | 703,050 | 0.0% | 0.03% | +133.3% |
| Q2 2022 | $2,201,000 | -45.1% | 703,050 | 0.0% | 0.01% | -47.8% |
| Q1 2022 | $4,007,000 | -41.8% | 703,050 | 0.0% | 0.02% | -30.3% |
| Q4 2021 | $6,883,000 | -90.8% | 703,050 | 0.0% | 0.03% | -89.9% |
| Q3 2021 | $74,432,000 | +24.0% | 703,050 | 0.0% | 0.33% | +23.9% |
| Q2 2021 | $60,019,000 | -25.6% | 703,050 | 0.0% | 0.26% | -24.6% |
| Q1 2021 | $80,696,000 | -19.3% | 703,050 | -1.6% | 0.35% | -7.2% |
| Q4 2020 | $99,995,000 | +75.8% | 714,250 | +2.3% | 0.38% | +66.1% |
| Q3 2020 | $56,890,000 | +7.6% | 698,469 | -5.0% | 0.23% | -2.6% |
| Q2 2020 | $52,851,000 | +61.5% | 735,469 | 0.0% | 0.23% | +15.3% |
| Q1 2020 | $32,721,000 | +1.0% | 735,469 | +116.5% | 0.20% | +17.4% |
| Q4 2019 | $32,393,000 | +21.3% | 339,690 | 0.0% | 0.17% | -5.5% |
| Q3 2019 | $26,710,000 | – | 339,690 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
| Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
| TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
| Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
| Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
| Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
| NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
| COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
| BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
| Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |